65 related articles for article (PubMed ID: 12649370)
21. Angiotensin receptor subtype mediated physiologies and behaviors: new discoveries and clinical targets.
Wright JW; Yamamoto BJ; Harding JW
Prog Neurobiol; 2008 Feb; 84(2):157-81. PubMed ID: 18160199
[TBL] [Abstract][Full Text] [Related]
22. Kinetic studies on aminopeptidase M-mediated degradation of human hemorphin LVV-H7 and its N-terminally truncated products.
John H; John S; Forssmann WG
J Pept Sci; 2008 Jul; 14(7):797-803. PubMed ID: 18236385
[TBL] [Abstract][Full Text] [Related]
23. Angiotensin AT4 ligands are potent, competitive inhibitors of insulin regulated aminopeptidase (IRAP).
Lew RA; Mustafa T; Ye S; McDowall SG; Chai SY; Albiston AL
J Neurochem; 2003 Jul; 86(2):344-50. PubMed ID: 12871575
[TBL] [Abstract][Full Text] [Related]
24. Endogenous cystinyl aminopeptidase in Chinese hamster ovary cells: characterization by [125I]Ang IV binding and catalytic activity.
Demaegdt H; Vanderheyden P; De Backer JP; Mosselmans S; Laeremans H; Le MT; Kersemans V; Michotte Y; Vauquelin G
Biochem Pharmacol; 2004 Sep; 68(5):885-92. PubMed ID: 15294451
[TBL] [Abstract][Full Text] [Related]
25. Cyclic insulin-regulated aminopeptidase (IRAP)/AT4 receptor ligands.
Axén A; Lindeberg G; Demaegdt H; Vauquelin G; Karlén A; Hallberg M
J Pept Sci; 2006 Nov; 12(11):705-13. PubMed ID: 16967438
[TBL] [Abstract][Full Text] [Related]
26. Structure-activity study of LVV-hemorphin-7: angiotensin AT4 receptor ligand and inhibitor of insulin-regulated aminopeptidase.
Lee J; Mustafa T; McDowall SG; Mendelsohn FA; Brennan M; Lew RA; Albiston AL; Chai SY
J Pharmacol Exp Ther; 2003 Apr; 305(1):205-11. PubMed ID: 12649370
[TBL] [Abstract][Full Text] [Related]
27. The angiotensin IV/AT4 receptor.
Chai SY; Fernando R; Peck G; Ye SY; Mendelsohn FA; Jenkins TA; Albiston AL
Cell Mol Life Sci; 2004 Nov; 61(21):2728-37. PubMed ID: 15549174
[TBL] [Abstract][Full Text] [Related]
28. Alzheimer's, angiotensin IV and an aminopeptidase.
Albiston AL; Fernando R; Ye S; Peck GR; Chai SY
Biol Pharm Bull; 2004 Jun; 27(6):765-7. PubMed ID: 15187413
[TBL] [Abstract][Full Text] [Related]
29. Targeting the insulin-regulated aminopeptidase/AT4 receptor for cognitive disorders.
Hallberg M
Drug News Perspect; 2009 Apr; 22(3):133-9. PubMed ID: 19440555
[TBL] [Abstract][Full Text] [Related]
30. Development of cognitive enhancers based on inhibition of insulin-regulated aminopeptidase.
Chai SY; Yeatman HR; Parker MW; Ascher DB; Thompson PE; Mulvey HT; Albiston AL
BMC Neurosci; 2008 Dec; 9 Suppl 2(Suppl 2):S14. PubMed ID: 19090987
[TBL] [Abstract][Full Text] [Related]
31. Opioid peptides derived from hemoglobin: hemorphins.
Zhao Q; Garreau I; Sannier F; Piot JM
Biopolymers; 1997; 43(2):75-98. PubMed ID: 9216245
[TBL] [Abstract][Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]